NutriBand (NTRB) Non Operating Income (2019 - 2026)
NutriBand's (NTRB) quarterly Non Operating Income came in at $52856.0 in Q1 2026, up 24.82% year-on-year from $42345.0 in Q1 2025, and up 563.27% quarter-over-quarter from $7969.0 in Q4 2025.
NutriBand (NTRB) Non Operating Income (2019 - 2026) Analysis & Trends
NutriBand has disclosed Non Operating Income across 8 years of filings, most recently posting $52856.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at $52856.0, up 24.82% year-over-year; the trailing twelve-month figure through Jan 2026 was $88329.0 (up 144.66% YoY), and the FY2026 annual result was $88329.0, up 144.66% from the prior year.
- Non Operating Income came in at $52856.0 for Q1 2026 at NutriBand, up from $7969.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $6.7 million in Q1 2022 to a low of -$574617.0 in Q1 2024.
- The 5-year median for Non Operating Income is $2649.0 (2023), against an average of $350351.5.
- Across the five-year window, Non Operating Income surged 9583.63% in 2022 and plunged 13729.44% in 2024, its largest moves.
- NutriBand's Non Operating Income stood at -$3966.0 in 2022, then plunged by 818.68% to -$36435.0 in 2023, then jumped by 276.22% to $64204.0 in 2024, then tumbled by 87.59% to $7969.0 in 2025, then surged by 563.27% to $52856.0 in 2026.
- The last three Non Operating Income figures came in at $52856.0 (Q1 2026), $7969.0 (Q4 2025), and $2876.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 9.35 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 52,856.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 52,856.00 |
| Oct 31, 2025 | 7,969.00 |
| Jul 31, 2025 | 2,876.00 |
| Apr 30, 2025 | 24,628.00 |
| Jan 31, 2025 | 42,345.00 |
| Oct 31, 2024 | 64,204.00 |
| Jul 31, 2024 | -295,723.00 |
| Apr 30, 2024 | -8,600.00 |
| Jan 31, 2024 | -574,617.00 |
| Oct 31, 2023 | -36,435.00 |
| Jul 31, 2023 | -4,985.00 |
| Apr 30, 2023 | 2,649.00 |
| Jan 31, 2023 | 4,216.00 |
| Oct 31, 2022 | -3,966.00 |
| Jul 31, 2022 | -4,429.00 |
| Apr 30, 2022 | -4,110.00 |
| Jan 31, 2022 | 6.69 Mn |
| Oct 31, 2021 | -33,380.00 |
| Jul 31, 2021 | -37,681.00 |
| Apr 30, 2021 | -993.00 |